Wetreated two cases of renal hypouricemia with nephrolithiasis. The serum uric acid level of the first patient was 1.5 mg/dl, and the ratio of uric acid clearance to creatinine clearance (CWCcr) was 75.7%. In the benzbromarone (BZB) suppression test, CWCcrwas increased from 60.4% to 130.0%, but was not decreased in response to the pyrazinamide (PZA) suppression test. This patient was considered to have a presecretory reabsorptive urate transportation defect. His condition was also associated with IgA nephropathy. The serum uric acid level in the second patient was 1.0 mg/dl and CWCcrwas 56.0%. Neither PZA nor BZB had a significant effect on CWCcr.
Introduction
Renal hypouricemia is a comparatively rare disease that was first described by Praetorius and Kirk in 1950 (1) . This disease usually produces no symptomsor morbidity, but uric acid nephrolithiasis does develop. Herein, we report two patients with uric acid nephrolithiasis, probably caused by abnormal renal tubular urate handling.
Case Reports Case1
A 57-year-old man was admitted to our hospital because of sudden right flank pain. Urinalysis showed microhematuria and proteinuria, and ultrasonography revealed hydronephrosis in his right kidney. Nephrolithiasis was suspected. The next day, the stone wasspontaneouslyexpulsed. Compositionanalysis revealed that the stone was composed of uric acid (91%) and calcium oxalate (9%). Laboratory data revealed that his uric acid level was markedly decreased. On physical examination, the patient's general condition appeared to be fair, and he was not emaciated (height 160 cm, weight 60 kg). His blood pressure was 158/80 mmHg,and his radial pulse rate was 72/ min and regular. Examination of his chest and nervous system revealed nothing unusual, and no edema was seen. He had no
Kayser-Fleischer ring. Table 1 shows his laboratory data on admission. He had been found to have proteinuria and hematuria on occasional routine health examinations since he was 25 years old, but he had not been treated. Urinalysis was positive for protein. The sediment contained 10 to 20 red blood cell (RBC)/high power field (HPF), granular casts and hyaline casts. The marked abnormalities found in biochemical tests were an unusually low level of serum uric acid, high levels of serum immunoglobulin A (IgA), and high levels of CH50. No other abnormalities were found in the biochemical tests, including amino acid patterns of his serum and urine. Serum oxypurine (xanthine and hypoxanthine) concentration was measured by high pressure liquid chromatography (HPLC).
Xanthine concentration was 0.4 jug/ml (normal range: 0.25-1.12 |ig/ml) and hypoxanthine concentration was 2.5 Jig/ml (normal range: 1.97-3. 1 1 Jig/ml). Ceruloplasmin concentration was 31.7 mg/dl and serum copper was 125 |J,g/dL Fasting blood sugar (FBS) was 102 mg/dl and HbAlc was 4.8%. His urinary calcium excretion, determined on an unrestricted diet, was 1 10 mg/day (normal range: 100-300 mg/day) and phosphorus excretions was 0.6 g/day (normal range: 0.5-1.0 g/day). His endogenouscreatinine clearance rate was 58.9 ml/min. Phenolsul-fonphthalein excretion rate was 24%in 15 minutes. Arterial blood gas was normal, and urinary p2-micr°gl°bulin (BMG) and N-acethyl-D-glucosaminidase (NAG) levels were 
Case2
A 33-year-old man was admitted to our hospital because of sudden left flank pain. Ultrasonography revealed hydronephrosis in his left kidney, and nephrolithiasis was suspected. The stone was spontaneously expulsed the next day, but was not analyzed. Laboratory data revealed that his serum uric acid level was markedly decreased. He had been healthy except for an appendectomy. A physical examination revealed no abnormalities, his height was 169 cm, weight 90.5 kg, blood pressure 128/80 mmHg,and pulse rate 78/min and regular. He had no Kayser-Fleischer ring. Results Tables 2 and 3 show the results of the pyrazinamide suppression tests and benzbromarone tests. In case 1 , benzbromarone increased the ratio of uric acid clearance to creatinine clearance (CuA/Ccr) from 60.4% to 130.0%. Subsequently, this ratio was not decreased in response to pyrazinamide. In case 2, neither pyrazinamide nor benzbromarone had any significant or anticipated effects on Cua or CuA/Ccr. In the proximal tubular function tests, percent TRP was 7 1 % in patient-1 and 85% in patient-2. The percentage TRP in patient-1 was slightly lower than in patient-2, but the parathyroid hormone(PTH) values of the two patients were within the normalrangebetween 130--490 pg/ml: the PTH level was 380 pg/ml in patient-1 and 290 pg/ml in patient-2. In patient-1 , the PAHclearance measured at a plasma PAHconcentration of 2.46 mg/dl was 390.2 ml/min. The TmPAHobtained when the plasma PAHlevel was elevated to 57.0 mg/dl was 104.5 mg/ min, which was slightly high compared with the normal value of69.6-92.2 mg/min, but there was apossibility thatthis data was within the limit of error (Table4). Inpatient-2, thePAH clearance measured at a plasma concentration of 2.0 1 mg/dl was 388.0 ml/min. The TmPAHat aplasmaPAHlevelof52.2mg/ dl was 24.3 mg/min and was low compared with the normal value (Table 4) . 
Family Studies
The first patient's mother, three brothers and two sons were normal on blood examination and hypouricemia was ruled out. The second patient's father, mother and two brothers were also normal and hypouricemia was also ruled out. Noneof their family members had glucosuria or proteinuria.
Discussion
Hypouricemia with serum uric acid levels persistently around 2 mg/dl is comparatively rare. This disease is caused either by diminished production of uric acid, or by increased excretion of uric acid (3) . An example of the former type ofhypouricemia is xanthinuria, or the administration of allopurinol. The latter condition, renal uricosuria with hypouricemia, is seen in various disorders, such as Fanconi's syndrome and Wilson's disease. These two patients showed hypouricemia and increased uric acid excretion, and were carefully examined in an effort to discover any underlying disorders which may cause hypouricemia. However, generalized defects in tubular transport shown by aminoaciduria, glucosuria, and hyperphosphaturia were not found. According to recent studies (4-6), renal regulation of uric acid excretion in man occurs in the following sequence: 1) filtration of uric acid in the glomerulus 2) extensive reabsorption in the proximal tubule 3) massive secretion and 4) postsecretory reabsorption of secreted uric acid. Increased uric acid clearance might result from enhanced secretion or diminished reabsorption of either filtered or secreted uric acid. Three grams of pyrazinamide administered orally appears to result in almost selective inhibition of tubular urate secretion. It almost eliminates urate excretion in normal subjects. Benzbromarone or probenecid is believed to inhibit the post-secretory reabsorption of uric acid, though it mayalso affect other sites of urate transportation. Renal hypouricemia has been classified into the following five different types according to the effects of pyrazinamide and benzbromarone (7, 8) This patient is considered to have a pre-secretory reabsorptive defect in uric acid transportation. The second patient, on the contrary, showedno response to benzbromarone, and is considered to have a subtotal defect in urate transportation. Some groups found abnormalities in the handling of renal oxypurines in patients with hypouricemia, suggesting that oxypurines are transported by the samerenal transport mechanism as uric acid. Kawachi et al (9) and Kaneko et al (10) described a case of renal hypouricemia which was associated with increased serum oxypurines levels caused by renal tubular dysfunction. The decreased serum hypoxanthine level observed in patient-2, might suggest the presence of abnormal renal hypoxanthine handling, however we could not prove this because it is difficult to measure the concentration of urinary oxypurines. Since the mechanismof renal oxypurines handling still remains obscure, the excretion of oxypurines in patients with renal hypouricemia must be investigated further.
There have been a few reports describing renal tubular PAH transport in renal hypouricemia, though PAHis thought to be secreted by a different transport mechanism than that of urate (1 1). Matsuda et al ( 12) reported on apatient with hypouricemia who had increased TmPAH. Urate excretion in this patient was only minimally suppressed by PZA, and paradoxically decreased by probenecid, suggesting that not only the pre-secretory but also the post-secretory reabsorption of urate is impaired. In the present patients the TmPAHlevel of^atient-1 was slightly increased and this might be within the limit of error. While the TmPAH level of patient-2 was apparently decreased, indicating that patient-2 has proximal tubular abnormalities related to uric acid and PAH. The first case was associated with IgA nephropathy. A case with renal hypouricemia associated with IgA nephropathy has only been described once (13, 14) . Fujiwara et al (13) found no cases of glomerulonephritis in which the renal tubular transport of uric acid was solely affected, except for a coincidental association. However, Tofuku et al ( 14) reported a patient with IgA nephropathy associated with renal hypouricemia. In their case,the patient's renal function decreased gradually over a 15-year period, resulting in chronic renal failure. The serum uric acid levels in that patient increased linearly from 1.0 mg/dl to 5.0 mg/dl in parallel with an increase in the serum creatinine level, but the CuA/Ccrratio did not change significantly during the 1 5 years. They pointed out that these changes were different from those found in patients with chronic glomerulonephritis, in which the serum uric acid level had no correlation with the serum creatinine level above 2.0 mg/dl, and the CuA/Ccr ratio had exponentially increased after the Ccr rate decreased below 30-40 ml/min. Patient-1 of the present study is the second case that was diagnosed with IgA nephropathy associated with hypouricemia. Long-term follow-up of the serum uric acid, creatinine, and CuA/Ccr ratio of this case may help to understand the relationship between renal tubular urate transport and glomerular function. At present, the slight decrease in renal function in Patient-1 is probably due to the progression of IgA nephropathy, and prolonged uricosuria might have affected his renal function. Renal hypouricemia is not fatal and the patients remain asymptomatic in their daily lives except for the occurrence of nephrolithiasis ( 1 5, 16) or exercise-induced acute renal failure (17) . Patients with renal hypouricemia seem to have a hereditary background of this abnormality (18) , although our two patients seemed to have idiopathic renal hypouricemia because disorders which may cause hypouricemia were not found in their families. Therefore it is likely that there are many latent patients with renal hypouricemia, who might be incidentally discovered in the future.
